For flexible and fast High Content Analysis

Chalfont St. Giles, UK, April 27th, 2009 – GE Healthcare, a unit of General Electric Company (NYSE: GE), has launched the IN Cell Analyzer 2000, a flexible cell imaging system for High Content Analysis with excellent image quality, speed and ease-of-use for all screening and research needs. The flexibility of the system enables scientists to perform a wide variety of previously challenging experiments with a single instrument: from investigative microscopy through to automated screening, and imaging of organelles, cells, tissues and whole organisms.

The IN Cell Analyzer 2000 has a unique combination of hardware and software features for extremely fast image acquisition making it ideal for screening. The robust construction of the instrument (designed using Six Sigma principles) ensures its reliability for high throughput use when carrying out demanding applications in a multi-user environment.

The system has a number of new enabling features, including:

Rapid preview scanning of a selected area of a sample at any available magnification prior to starting an acquisition run

High performance large chip CCD camera coupled with a widefield illumination source that is twice as bright as a conventional xenon lamp, ensuring more statistically robust results in a single pass

Whole-well imaging to capture an entire well in a single image, enhancing the ability to image rare events

Wide range of objectives (2x – 100x) to suit a variety of sensitivity requirements

Six imaging restoration modes to ensure high quality images and accurate data with any sample type

Fast image acquisition from slides using Preview scan and a new intuitive graphical user interface

A manual microscope mode allowing settings to be adjusted and effects assessed in real time

“The IN Cell Analyzer 2000 was developed to address the needs of the entire high-content imaging workflow: combined with intuitive software, as well as expert instrument and applications support, even the most challenging high content assays are now an every day reality. Cell analysis just got easier,” says Leighton Howells, Program Manager, at GE Healthcare. “The launch of the IN Cell Analyzer 2000 exemplifies our commitment to the continued development of leading solutions for cell imaging scientists.”

The instrument will be showcased at the SBS 15th Annual Conference and Exhibition, at booth 166. Customers can also register for several events focusing on High Content Analysis at the event, including tutorials, Q&A sessions with experts in high content analysis and poster sessions.

For more information please visit: www.gehealthcare.com/incell

For a high-resolution image please contact College Hill

-ENDS-

Notes for editors:

About High Content Analysis

High Content Analysis (HCA) and High Content Screening (HCS) are essential tools in many areas of life science research and drug discovery. HCA employs cellular assays in a high throughput imaging and analysis format, which allows researchers to do more complex experiments, to increase the number of questions they can ask whilst simultaneously decreasing the time taken to achieve their results. In contrast to established methods such as microscopy, western blotting or flow cytometry, HCA is non-destructive and much less time consuming, making it easier and more efficient for scientists to study cellular processes in their true biological context. This enables researchers to obtain better data and gain more knowledge about cellular systems in a much shorter time.

About GE Healthcare’s IN Cell Analyzer

IN Cell Analyzer is a modular imaging system for fast and automated High Content Analysis (HCA). This advanced and highly sensitive platform enables scientists to study cellular processes in their true biological context, in research and drug discovery. It offers high-throughput microscopy in combination with modern cellular assays and robotic handling for automated cellular imaging and analysis. The IN Cell Analyzer provides one of the most versatile HCA portfolios on the market and is exceptional in its modularity, completeness and ease of use. It has been recognized by the 2007 Frost & Sullivan Technology Innovation Award. For more detailed information on the IN Cell suite, visit www.gehealthcare.com/incell

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare’s broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new “early health” model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 47,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.